Announced Mon, 14 Jul · 12:56 IST

Healthcare Global Enterprises Limited has informed the Exchange about the submission of recommendation of Committee of Independent Directors ( IDC ) under Regulation 26(7) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011 and Newspaper publication in this regard

Listed Co AcquisitionOpen Offer TriggeredStrategic Transactions View source PDF

HCG · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

HCG has submitted to the stock exchanges the recommendation of its Committee of Independent Directors on the open offer made by Hector Asia Holdings II Pte. Ltd. (along with PACs including KKR Asia IV Fund Investments and KIA EBT II Scheme 1). The offer is to acquire up to 3,70,90,327 equity shares (26% of expanded voting share capital) from public shareholders at INR 504.41 per share, aggregating to roughly INR 1,870.87 crores in cash. The IDC, after reviewing the offer documents, noted that the 60-day VWAP on NSE preceding the public announcement was INR 504.41 and the highest negotiated price under the share purchase agreement was INR 445. The IDC unanimously concluded that the offer price of INR 504.41 is fair and reasonable and in compliance with SEBI Takeover Regulations. The recommendation was published in Financial Express, Jansatta, Navshakti, and Vishwavani on July 14, 2025.

Likely market impact

This is a mandatory procedural step in the ongoing takeover process and is broadly neutral to slightly positive — the IDC has endorsed the KKR-led open offer price as fair, giving public shareholders clarity. Shareholders now have a defined window to evaluate and tender shares at INR 504.41 in cash.